Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial
Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page
- Check7 days agoChange DetectedNo additions or deletions were provided to describe changes for this page.SummaryDifference0.2%

- Check14 days agoChange DetectedThe page now indicates that recruitment is closed for this study and includes new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study). It also updates the Interventions headings by adding 'Intervention/Treatment', removing 'Intervention / Treatment', and updates the revision tag to v3.6.0.SummaryDifference0.6%

- Check21 days agoChange DetectedThe page now reflects a new site revision, showing Revision: v3.5.5 replacing the previous v3.5.4; this indicates a minor update to the site's underlying versioning rather than changes to study content.SummaryDifference0.3%

- Check28 days agoChange DetectedNo content changes were detected; the study page content remains unchanged. The page continues to present the overview, design, outcomes, eligibility criteria, and locations as currently shown.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page revision stamp was updated from v3.5.3 to v3.5.4, signaling a maintenance update to the record rather than a substantive change to the trial content.SummaryDifference0.3%

- Check50 days agoChange DetectedNo additions or deletions were reported, so the page content remains unchanged.SummaryDifference0.2%

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.